相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Frequency of TERT Promoter Mutations in Real-World Analysis of 2,092 Thyroid Carcinoma Patients
Heera Yang et al.
ENDOCRINOLOGY AND METABOLISM (2022)
A Narrative Review of Genetic Alterations in Primary Thyroid Epithelial Cancer
Cristina Romei et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Significance of telomerase reverse-transcriptase promoter mutations in differentiated thyroid cancer
Hung-Fei Lai et al.
FORMOSAN JOURNAL OF SURGERY (2021)
BRAFV600E Mutation is Associated with an Increased Risk of Papillary Thyroid Cancer Recurrence
Samuel Enumah et al.
WORLD JOURNAL OF SURGERY (2020)
Papillary Thyroid Cancer-Aggressive Variants and Impact on Management: A Narrative Review
Andres Coca-Pelaz et al.
ADVANCES IN THERAPY (2020)
Artificial intelligence to predict the BRAFV600E mutation in patients with thyroid cancer
Jiyoung Yoon et al.
PLOS ONE (2020)
The Coexistence of Genetic Mutations in Thyroid Carcinoma Predicts Histopathological Factors Associated With a Poor Prognosis: A Systematic Review and Network Meta-Analysis
Ling Zhao et al.
FRONTIERS IN ONCOLOGY (2020)
Association between TERT promoter mutations and clinical behaviors in differentiated thyroid carcinoma: a systematic review and meta-analysis
Jing Yang et al.
ENDOCRINE (2020)
Highly prevalent BRAF V600E and low-frequency TERT promoter mutations underlie papillary thyroid carcinoma in Koreans
Sue Youn Kim et al.
JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE (2020)
Risk Stratification in Differentiated Thyroid Cancer: From Detection to Final Follow-Up
R. Michael Tuttle et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
Current trends in the features of male thyroid cancer Retrospective evaluation of their prognostic value
Min Jhi Kim et al.
MEDICINE (2019)
Relevance and clinicopathologic relationship of BRAF V600E, TERT and NRAS mutations for papillary thyroid carcinoma patients in Northwest China
Meiling Huang et al.
DIAGNOSTIC PATHOLOGY (2019)
Interaction of BRAF-induced ETS factors with mutant TERT promoter in papillary thyroid cancer
Young Shin Song et al.
ENDOCRINE-RELATED CANCER (2019)
Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
TERT Promoter Mutation Predicts Radioiodine-Refractory Character in Distant Metastatic Differentiated Thyroid Cancer
Xue Yang et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
Molecular Profiling of Papillary Thyroid Carcinoma in Korea with a High Prevalence of BRAFV600E Mutation
Seung Eun Lee et al.
THYROID (2017)
Updated American Joint Committee on Cancer/Tumor-Node-Metastasis Staging System for Differentiated and Anaplastic Thyroid Cancer (Eighth Edition): What Changed and Why?
R. Michael Tuttle et al.
THYROID (2017)
Mortality Risk Stratification by Combining BRAF V600E and TERT Promoter Mutations in Papillary Thyroid Cancer Genetic Duet of BRAF and TERT Promoter Mutations in Thyroid Cancer Mortality
Rengyun Liu et al.
JAMA ONCOLOGY (2017)
The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more personalized approach to cancer staging
Mahul B. Amin et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
Prognostic effects of TERT promoter mutations are enhanced by coexistence with BRAF or RAS mutations and strengthen the risk prediction by the ATA or TNM staging system in differentiated thyroid cancer patients
Young Shin Song et al.
CANCER (2016)
Meta-Analyses of Association Between BRAF(V600E) Mutation and Clinicopathological Features of Papillary Thyroid Carcinoma
Qing Zhang et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2016)
TERT promoter mutations in thyroid cancer
Rengyun Liu et al.
ENDOCRINE-RELATED CANCER (2016)
TERT promoter mutations and long-term survival in patients with thyroid cancer
Tae Hyuk Kim et al.
ENDOCRINE-RELATED CANCER (2016)
BRAF and TERT promoter mutations in the aggressiveness of papillary thyroid carcinoma: a study of 653 patients
Langping Jin et al.
ONCOTARGET (2016)
TERT promoter Mutation and Its Association with Clinicopathological Features and Prognosis of Papillary Thyroid Cancer: A Meta-analysis
Chunping Liu et al.
SCIENTIFIC REPORTS (2016)
Association between screening and the thyroid cancer epidemic in South Korea: evidence from a nationwide study
Sohee Park et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Association between screening and the thyroid cancer epidemic in South Korea: evidence from a nationwide study
Sohee Park et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
TERT Promoter Mutations in Thyroid Cancer
Ali S. Alzahrani et al.
HORMONES & CANCER (2016)
Recurrent TERT promoter mutations identified in a large-scale study of multiple tumour types are associated with increased TERT expression and telomerase activation
Dong-Sheng Huang et al.
EUROPEAN JOURNAL OF CANCER (2015)
Korea's Thyroid-Cancer Epidemic - Screening and Overdiagnosis
Hyeong Sik Ahn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
The Frequency and Clinical Implications of the BRAFV600E Mutation in Papillary Thyroid Cancer Patients in Korea Over the Past Two Decades
A. Ram Hong et al.
ENDOCRINOLOGY AND METABOLISM (2014)
The Role of Telomeres in Stem Cells and Cancer
Cagatay Guenes et al.
CELL (2013)
Highly prevalent TERT promoter mutations in aggressive thyroid cancers
Xiaoli Liu et al.
ENDOCRINE-RELATED CANCER (2013)
Association Between BRAF V600E Mutation and Mortality in Patients With Papillary Thyroid Cancer
Mingzhao Xing et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Frequency of TERT promoter mutations in human cancers
Joao Vinagre et al.
NATURE COMMUNICATIONS (2013)
BRAFV600E mutation does not serve as a prognostic factor in Korean patients with papillary thyroid carcinoma
Dongbin Ahn et al.
AURIS NASUS LARYNX (2012)
The Impact of Distant Metastases at Presentation on Prognosis in Patients with Differentiated Carcinoma of the Thyroid Gland
Iain J. Nixon et al.
THYROID (2012)
Estimating Risk of Recurrence in Differentiated Thyroid Cancer After Total Thyroidectomy and Radioactive Iodine Remnant Ablation: Using Response to Therapy Variables to Modify the Initial Risk Estimates Predicted by the New American Thyroid Association Staging System
R. Michael Tuttle et al.
THYROID (2010)
Papillary thyroid carcinoma: Factors influencing recurrence and survival
Antonio Toniato et al.
ANNALS OF SURGICAL ONCOLOGY (2008)
Understanding and exploiting hTERT promoter regulation for diagnosis and treatment of human cancers
Satoru Kyo et al.
CANCER SCIENCE (2008)
The BRAF mutation is useful for prediction of clinical recurrence in low-risk patients with conventional papillary thyroid carcinoma
Tae Yong Kim et al.
CLINICAL ENDOCRINOLOGY (2006)
分享论文
